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Renal pathologists identify the protein component of renal
amyloid deposits by immunohistochemistry using antibodies
against known amyloidogenic proteins. The majority of
amyloid cases can be categorized by a simple antibody panel
that includes immunoglobulin light chains lambda and
kappa, and serum amyloid A. In some instances, however,
these reagents do not recognize materials that stain with
Congo red or yield ambiguous staining results, thus creating
a diagnostic dilemma. Chemical analysis of fibrils extracted
from such a nonreactive renal biopsy led to the discovery
of a previously unknown amyloid formed from leukocyte
chemotactic factor 2 (LECT2). Over the past 8 years, we
received 285 renal amyloid samples, of which 31 remained
unclassified. In an effort to determine whether any of the
latter samples were LECT2 related, tandem mass
spectrometry was performed. In all, 7 of the 31 cases were
identified as an amyloid LECT2 (ALECT2), a finding confirmed
immunohistochemically using a LECT2-specific antibody. The
deposits strongly stained for Congo red and, in most cases,
had distinctive morphological features with diffuse
involvement of the interstitium, arteries, and glomeruli.
Hence, we believe that ALECT2 represents the third common
form of renal amyloidosis.
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The diagnosis of amyloidosis is based on the finding of
characteristic extracellular amorphous material, which is
Congo red positive and apple green birefringent with
polarization. By electron microscopy, amyloid is composed
of characteristic randomly oriented, 7–10 nm nonbranching
fibrils. Despite its unifying morphology, all amyloid is not the
same. There are currently more than 25 proteins known to be
capable of forming amyloid,1 and new amyloid proteins are
still being described. This complexity is important to
recognize because the clinical management of this disease
varies widely depending on the responsible protein.
Systemic amyloidosis often involves the kidneys and is
diagnosed on renal biopsy. The most prevalent type,
designated AL, is derived from immunoglobulin light chains,
although many other kinds of amyloid deposit in this organ
include those formed from serum amyloid A protein (AA),
and, less commonly, fibrinogen (AFib), transthyretin
(ATTR), lysozyme (ALys), and apolipoproteins AI or AII
(AApoAI, AApoAII).1 Recently, yet another example of renal
amyloidosis—namely that composed of leukocyte chemotac-
tic factor 2 (LECT2)—was described and exhibited extensive
congophilic deposits in the glomeruli, interstitium, and
vessels.2 In an effort to identify additional cases of ALECT
(LECT2-associated amyloidosis), we conducted a retro-
spective study that involved 31 previously unclassified
samples (out of 285 amyloid-containing specimens) received
in our laboratory over the past 8½ years in which the
nature of the deposits could not be established immunohis-
tochemically.
In this report, we describe seven new cases of LECT2
amyloidosis and provide information on the morphological
pattern of this form of renal amyloidosis.
RESULTS
Among the 21,598 kidney biopsy specimens sent to our
laboratory over the past 8½ years, 285 (1.3%) were found
histochemically to contain apple green birefringent congo-
philic deposits that, by electron microscopy, were observed
to have typical ultrastructural features of amyloid. The
two most common forms of amyloidosis identified were
AL (86.3%) or AA (7.0%) (Table 1). The majority of cases
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were identified immunologically; however, 31 instances could
not be typed when immunostained by anti-k, anti-l,
anti-AA, or anti-fibrinogen antisera either due to the absence
of staining or ambiguous staining. To determine the nature of
the amyloid in these cases, the material was extracted and
chemically analyzed by tandem mass spectrometry. In seven
instances, the periodic acid-Schiff-negative deposits were
identified as LECT2 and this finding was confirmed
immunohistochemically (Figure 1). Among the remaining
24, the amyloid in 4 was composed of transthyretin (ATTR);
in 1, it was derived from immunoglobulin-g heavy chain
(AH); in 6, it was composed of AL; 6 others were derived
from AA; and in 7, there was insufficient sample for analysis.
It was noteworthy that the LECT2-associated amyloid was
intensely congophilic, as compared with that formed from
light chain, serum amyloid A, or transthyretin.
The mean age of patients with LECT2 amyloidosis was 67.8
years (range: 58–84 years). There were a total of four women
and three men. Five of seven patients were Hispanic. There
was one Caucasian (1/7) and one Native American (1/7).
There was extensive amyloid deposition in all cases of
LECT2 amyloidosis. The interstitial compartment was
involved in all seven cases, with all but one showing striking
and diffuse interstitial deposition. The mesangial regions
showed marked, diffuse, global expansion, and displacement
by congophilic deposits, in all cases with one exception
(Figure 1). In addition, many of the arteries and arterioles
were affected (Table 2).
Figure 1 | LECT2-associated renal amyloidosis (light microscopy). (a) Extensive mesangial replacement by periodic acid-Schiff and
(b) Jones methenamine silver-negative amorphous material ( 400). (c) Reactivity of glomerular and interstitial amyloid deposits with
an anti-LECT2 antibody (immunoperoxidase technique,  100). (d) Uptake of Congo red stain by interstitial and glomerular amyloid
deposits ( 100). LECT2, leukocyte chemotactic factor 2.
Table 1 | Frequency of amyloid type in 285 renal biopsy
specimens
Amyloid type Number Percentage (%)
AL 246 86.3
AA 20 7.0
ALECT2 7 2.5
ATTR 4 1.4
AH 1 0.3
Unknown 7 2.5
Abbreviations: AA, serum amyloid A-associated amyloid; AH, heavy chain-associated
amyloid; AL, light chain-associated amyloid; ALECT2, leukocyte chemotactic factor 2-
associated amyloid; ATTR, transthyretin-associated amyloid.
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DISCUSSION
The morphological pattern of amyloid distribution in all
LECT2 specimens was similar to that reported originally,2
that is, with extensive involvement of all compartments of the
kidney. In this respect, LECT2 deposition differed somewhat
from other types of renal amyloid. For example, the amyloid
formed from fibrinogen A a-chain is strikingly selective for
the glomeruli;3 apolipoprotein AI is reported to be restricted
to the medullary interstitium, with conspicuous absence
from the cortex in both the interstitium and the glomeruli;4
AA predominately targets the glomeruli, but occasionally is
seen in the vasculature with little or no deposition within the
glomeruli or interstitium.5
Immunohistochemistry is the usual method used for
typing renal amyloid and, in one report, successfully showed
the amyloid type in 96.6% of cases.1 However, it comes with
diagnostic pitfalls and occasionally cases are not able to be
definitively typed using this method. Many of these unknown
cases represent AL amyloid, which is occasionally nonreactive
with commercial light-chain antibodies,6 but it is also
possible that these unknown cases represent a rare form of
amyloid, which was not tested for, or even an as yet
uncharacterized amyloid. Chemical analysis of formalin-fixed
paraffin-embedded tissue by tandem mass spectrometry was
used in this study to determine the nature of the amyloid
protein in cases that could not be typed by our routine
immunohistochemical panel. Depending on the size of the
biopsy specimen and the amount of amyloid present, as few
as four to six 4-mm-thick sections may be sufficient to make a
diagnosis of amyloid type using this method. In some cases,
in which no tissue remained in the paraffin block, results
were obtained from previously stained sections, such as
hematoxylin and eosin, Jones methenamine silver, Masson
trichrome, and periodic acid-Schiff reagent.
Correct identification of the amyloid subtype prevents
confusion and additional testing often performed in the
setting of an unknown type of amyloidosis. Even more
importantly, it prevents potentially dangerous therapy, which
can occur if it is wrongly concluded that the amyloid,
although not staining for k- or l-light chains, is due to
abnormal paraprotein production caused by a subtle plasma
cell dyscrasia. This may lead to the incorrect use of
chemotherapy and even bone marrow transplantation.
Little is known about the pathogenesis or prognosis of
LECT2 amyloidosis. The process seemingly is confined to the
kidney; however, there are only limited chemical and no
postmortem data on patients with this disorder. In contrast
to other types of renal amyloid, LECT2, which is produced by
the liver,7 is neither mutated,2 an acute-phase reactant, nor a
product of a clonal population.8
In summary, ALECT2 was the third most common form
of renal amyloidosis in our series. Therefore, we recommend
that nephropathologists consider this diagnosis in cases that
are ‘non-reactive’ with conventionally used immunohisto-
chemical reagents and especially in those with strong
congophilia, extensive mesangial expansion, and diffuse
interstitial and vascular involvement.
MATERIALS AND METHODS
Light microscopy
Briefly, kidney biopsies were fixed in buffered formalin, dehydrated
in graded alcohols, and embedded in paraffin using standard
techniques. Serial 3-mm-thick sections were cut and treated with
hematoxylin and eosin, Jones methenamine silver, Masson tri-
chrome, and periodic acid-Schiff reagent. In addition, the tissue was
stained with Congo red wherein the diagnosis of amyloid was
confirmed by Congo red positivity with apple green birefringence
when viewed by polarizing microscopy.
Immunohistochemistry
Samples were placed in Michel’s media, washed in buffer, and frozen
in a cryostat. Sections, cut at 5 mm, were rinsed in buffer and reacted
with fluorescein-tagged polyclonal rabbit anti-human antibodies
to IgG, IgA, IgM, C3, C4, C1q, fibrinogen, and k-, and l-light
chains (all from Dako, Carpenteria, CA, USA) for 1 h, rinsed, and
a coverslip applied using aqueous mounting media. For AA
and LECT2 detection, 4-mm-thick paraffin-embedded sections
were cut, deparaffinized, rehydrated, and blocked with normal
horse serum for 5min, followed by reaction for 1 h with a
1:200 dilution of mouse anti-human amyloid A protein mAb
(DakoCytomation, Glostrup, Denmark) or a 1:40 dilution of a goat
anti-human LECT2mAb (R&D Systems, Minneapolis, MN, USA).
Immunoreactions were visualized using 3,3’-diaminobenzidine as
the substrate (Vector Laboratories, Burlingame, CA, USA).
Electron microscopy
Pieces of 1-mm thickness were removed from each end of the renal
biopsy specimen and dehydrated using graded alcohols, followed by
embedding in epon/araldite embedding resin. Sections of 1-mm
thickness sections were cut using an ultramicrotome, stained with
toluidine blue, and examined in a Jeol JEM-1011 electron
microscope (Jeol, Tokyo, Japan). Photomicrographs were routinely
taken at  5000,  12,000, and  20,000 magnifications. To
confirm the fibrillar nature of the deposits, appropriate areas were
examined at  50,000.
Chemical analysis
Amyloid fibrils were extracted from 8 to 30 4-mm-thick formalin-
fixed, paraffin-embedded sections using 6mol/l guanidine HCl
and, after reduction and alkylation, followed by trypsin digestion,
were analyzed by tandem mass spectrometry, as described
previously.9,10
Table 2 | Distribution of LECT2-associated amyloid within the
kidney
Case no. Mesangium GBM Interstitium Arterioles Arteries
1 ++++a + ++++ ++ +++
2 ++++ +++ + ++ N/A
3 ++  +++ + ++
4 ++++ + ++++ ++ ++
5   ++++ + +
6 ++++ + ++++ +++ +
7 ++++  ++++ +++ 
Abbreviations: GBM, glomerular basement membrane; LECT2, leukocyte chemotac-
tic factor 2; N/A, arteries not present in specimen.
aLECT2 deposits: , absent; +, o25%; ++, 25–50%; +++, 50–75%; ++++, 75–100%.
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